Clinical Trial Update: Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With Generalized Social Anxiety Disorder [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports on the efficacy and tolerability of atomoxetine (Strattera) in adults with Generalized Social Anxiety Disorder, spanning Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Social Anxiety Disorder

Drugs mentioned

• Atomoxetine (Strattera) (Atomoxetine)

Snippet

Sponsor: University of California, San Diego | Conditions: Generalized Social Phobia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-03-11